What is CORT's current stock price?

As of now, CORT is trading at $34.80, with a daily change of -50.42%.

Market Overview Trending Stocks Stock Screener Trade Insights

Top Rated Stocks Most Active Stocks Top Potential Stocks Top Momentum Stocks Leaderboard

About Us Log In Sign Up Plans & Pricing Contact Us Terms of Use Privacy Policy

Find new investment opportunities based on Market Sentiment Indicator. Manage watchlist risk with leading indicator of volatility See what influential analysts and investors are saying about stocks in My Watchlist

CORT Stock Analysis & IQ Rating | Corcept Therapeutics

CORT

Corcept Therapeutics

$34.80

-$35.39 | -50.42%

Set Alerts

Overview

Comments

Insights

Risks

Rating

Chart

Analysts

Street

Sentiment

Headlines

alert Latest Updates

Night.Owl Yesterday at 08:35

Intelligent Bio Solutions completely dominated trader attention today with explosive volatility. The stock swung through dramatic gains after announcing a new manufacturing partnership expected to cut costs and expand gl...

BQ Stock IQ

Login to see Corcept Therapeutics (CORT) Stock IQ rating and get instant clarity on whether to Buy, Hold, or Avoid

CORT Target Price

Login to display

Strengths

CORT Rewards

Upgraded on attractively valued

CORT Rewards

Earnings are forecast to grow

CORT Rewards

Trading below its fair value

Technical Indicators

CORT Technical Indicators

Oversold

CORT Price Performance

$84.66 (-58.89%)

$89.91 (-61.29%)

$71.96 (-51.64%)

$55.31 (-37.08%)

1year

6month

3month

1month

CORT Risk Level

CORT has Low risk level based on volatility, sector strength, volume, investor confidence and outlook.

Click here to check what is your level of risk

Low

LOW

HIGH

CORT Analysts Opinion

CORT overall standing based on key factors, offering insights into analysts perspectives and market expectations.
menu Hover over the category for more information

CORT Analysts Opinion

CORT Analysts opinion is positive but there was a setback from the past 3 months

CORT Street Sentiment

Analysts perspectives on the stock desirability, trend direction and growth potential

46%

Buy
Opinion

Trend
Score

Potential
Score

Consensus Rating

0%

25%

100%

CORT Street Sentiment

CORT Street Sentiment is bullish and have positive views on the near-term outlook

CORT Performance Sentiment

Sentiments overview associated with CORT events and the stock performance.

46%

38%

Positive

Negative

6 out of 13
events present

5 out of 13
events present

Very Bullish

Bullish

Neutral

Bearish

Very Bearish

Technical Price Levels

Average key support and resistance price levels

Support
Price

$34.80

Resistance
Price

$34.80

Current Price Range

$87.99

Show methods +

CORT Latest Analysis +

Why Corcept Therapeutics Plummeted by 50% Today. Key PointsThe FDA declined to approve its relacorilant.

Today

$34.80 | -50.42%

Momentum

Corcept Stock Plunges 50% After FDA Rejects Relacorilant Application . (RTTNews) - Corcept Therapeutics Incorporated (CORT) shares fell 50.50% trading at $34.74 down $35.45 after the company announced it received a Complete Response Letter (CRL) from the United States Food and Drug Administration regarding its relacorilant application.

Today

$34.80 | -50.42%

Activity

Corcept Receives FDA Complete Response Letter For Relacorilant Stock Down . (RTTNews) - Corcept Therapeutics (CORT) on Wednesday said the United States Food and Drug Administration has issued a Complete Response Letter for the New Drug Application of relacorilant to treat hypertension secondary to hypercortisolism.

Today

$34.80 | -50.42%

Activity

Momentum

Corcept Therapeutics Stock Sinks On FDA Setback For Relacorilant. CORT) stock tumbled Wednesday after the .The commercial-stage company is engaged in the discovery and development of medications to treat severe endocrinologic oncologic metabolic and neurologic disorders by modulating the effects of the hormone cortisol.The United States Food and Drug Administration (FDA) on Wednesday issued a Complete Response Letter (CRL) regarding the New Drug Application (NDA) for relacorilant for hypertensio

Today

$34.80 | -50.42%

Momentum

Corcept Therapeutics (CORT) Shares Cross Below 200 DMA. In trading on Tuesday shares of Corcept Therapeutics Inc (Symbol: CORT) crossed below their 200 day moving average of $73.97 changing hands as low as $69.91 per share. Corcept Therapeutics Inc shares are currently trading off about 12.1% on the day. The chart below shows the

Tue Dec 30, 2025

$70.19 | -12.06%

Technical

Major Exercise Alert: Joseph K Belanoff Exercises Options Worth $41.51M At Corcept Therapeutics. A large exercise of company stock options by CORT) was disclosed in a new SEC filing on December 29 as part of an insider exercise.United States Securities and Exchange Commission revealed that Belanoff Chief Executive Officer at Corcept Therapeutics exercised stock options for 550000 shares of CORT resulting in a transaction value of $41508500.As of Tuesday morning Corcept Therapeutics Inc is a comm

Tue Dec 30, 2025

$70.19 | -12.06%

Activity

Noteworthy Friday Option Activity: CORT GEV SOFI. Among the underlying components of the Russell 3000 index we saw noteworthy options trading volume today in Corcept Therapeutics Inc (Symbol: CORT) where a total of 4480 contracts have traded so far representing approximately 448000 underlying shares. That amounts to about

Fri Dec 26, 2025

$82.65 | -1.12%

Momentum

UBS Initiates Coverage of Corcept Therapeutics (CORT) with Neutral Recommendation. Fintel reports that on December 16 2025 UBS initiated coverage of Corcept Therapeutics (NasdaqCM:CORT) with a Neutral recommendation. Analyst Price Forecast Suggests 69.88% Upside

Wed Dec 17, 2025

$82.28 | +1.43%

Potential

Rating

Wall Street Firms Tout Corcept Therapeutics Incorporated (CORT) Prospects on Korlym Medication Prospects. Corcept Therapeutics Incorporated (NASDAQ:CORT) is one of the best biotech stocks to buy according to Wall Street analysts. On November 25 H.C. Wainwright reiterated a Buy rating and a $145 price target on the stock citing its strong growth prospects despite commercial challenges. The research firm has reiterated its confidence in the companys Korlym medication [….]

Thu Dec 11, 2025

$87.13 | +2.13%

Potential

FAQ About CORT Stock Insights

What is CORT current stock price?

What are CORT stock strengths?

What is CORT Risk Level?

What is CORT market cap and volume?

What is CORT current Stock IQ?

Should I buy CORT stock right now?

Is CORT a Strong Buy right now?

What does a 'Strong Buy' rating mean for CORT?

What does a 'Strong Sell' rating mean for CORT?

What factors influence CORT's Stock IQ?

Explore our CORT Stock insights

In-Depth Market Analysis and Trends
Expert Insights on Market Dynamics
Tailored CORT Stock Strategies
Effective Risk Management

FIND US ON

Receive our CORT Daily Alerts

Join over 10,000+ subscribers who value exclusive insights. Stay ahead in the stock market! Enter your email for daily alerts

Market Trends

Stay ahead of the market

Market trends

Investment tips

Market analysis service

Investment Insights

Future potential

Informed investment decisions

Investment analysis

IInvestment strategies

Stock Analysis

In-depth stock analysis

Performance analysis

Stock market insights

Financial trends analysis

CORT

Corcept Therapeutics

Current Price

$34.80

-$35.39 | -50.42%

52W High

$117.33

MKT CAP

$3.66B

52W Low

$32.99

VOL

$20.26M

P/E Ratio

39.29

AVG VOL

$932.67K

RSI

14.61

TREND

Sideways

Set Alerts

Overview

Comments

Insights

Risks

Rating

Chart

Analysts

Street

Sentiment

Target Price

Login to display

Not Enough Information

Stock Insights

Strengths

CORT Rewards

Upgraded on attractively valued

CORT Rewards

Earnings are forecast to grow

CORT Rewards

Trading below its fair value

Technical Indicators

CORT Technical Indicators

Oversold

CORT Price Performance

$84.66 (-58.89%)

$89.91 (-61.29%)

$71.96 (-51.64%)

$55.31 (-37.08%)

1year

6month

3month

1month

CORT Analysts Opinion

CORT Overall standing by considering key factors, reflecting analysts perspectives and market expectations.
menu Hover over the category for more information

CORT Analysts Opinion

CORT Analysts opinion is positive but there was a setback from the past 3 months

CORT Street Sentiment

Analysts perspectives on the stock desirability, trend direction and growth potential

46%

Buy
Opinion

Trend
Score

Potential
Score

Consensus Rating

0%

25%

100%

CORT Street Sentiment

CORT Street Sentiment is bullish and have positive views on the near-term outlook

CORT Risk Level

CORT has Low risk level based on volatility, sector strength, volume, investor confidence and outlook.

Click here to check what is your level of risk

Low

LOW

HIGH

CORT Performance Sentiment

Sentiments overview associated with CORT events and the stock performance.

46%

38%

Positive

Negative

6 out of 13
events present

5 out of 13
events present

Very Bullish

Bullish

Neutral

Bearish

Very Bearish

Technical Price Levels

Average key support and resistance price levels

Support
Price

$34.80

Resistance
Price

$34.80

Current Price Range

$87.99

Show methods +

CORT Stock IQ

Login to unlock Corcept Therapeutics (CORT) Stock IQ rating and get instant clarity on whether to Buy, Hold, or Avoid

CORT Latest Analysis

Night.Owl Yesterday at 08:35

Intelligent Bio Solutions completely dominated trader attention today with explosive volatility. The stock swung through dramatic gains after announcing a new manufacturing partnership expected to cut costs and expand gl...

Why Corcept Therapeutics Plummeted by 50% Today. Key PointsThe FDA declined to approve its relacorilant.

Today

$34.80 | -50.42%

Momentum

Corcept Stock Plunges 50% After FDA Rejects Relacorilant Application . (RTTNews) - Corcept Therapeutics Incorporated (CORT) shares fell 50.50% trading at $34.74 down $35.45 after the company announced it received a Complete Response Letter (CRL) from the United States Food and Drug Administration regarding its relacorilant application.

Today

$34.80 | -50.42%

Activity

Corcept Receives FDA Complete Response Letter For Relacorilant Stock Down . (RTTNews) - Corcept Therapeutics (CORT) on Wednesday said the United States Food and Drug Administration has issued a Complete Response Letter for the New Drug Application of relacorilant to treat hypertension secondary to hypercortisolism.

Today

$34.80 | -50.42%

Activity

Momentum

Corcept Therapeutics Stock Sinks On FDA Setback For Relacorilant. CORT) stock tumbled Wednesday after the .The commercial-stage company is engaged in the discovery and development of medications to treat severe endocrinologic oncologic metabolic and neurologic disorders by modulating the effects of the hormone cortisol.The United States Food and Drug Administration (FDA) on Wednesday issued a Complete Response Letter (CRL) regarding the New Drug Application (NDA) for relacorilant for hypertensio

Today

$34.80 | -50.42%

Momentum

Corcept Therapeutics (CORT) Shares Cross Below 200 DMA. In trading on Tuesday shares of Corcept Therapeutics Inc (Symbol: CORT) crossed below their 200 day moving average of $73.97 changing hands as low as $69.91 per share. Corcept Therapeutics Inc shares are currently trading off about 12.1% on the day. The chart below shows the

Tue Dec 30, 2025

$70.19 | -12.06%

Technical

Major Exercise Alert: Joseph K Belanoff Exercises Options Worth $41.51M At Corcept Therapeutics. A large exercise of company stock options by CORT) was disclosed in a new SEC filing on December 29 as part of an insider exercise.United States Securities and Exchange Commission revealed that Belanoff Chief Executive Officer at Corcept Therapeutics exercised stock options for 550000 shares of CORT resulting in a transaction value of $41508500.As of Tuesday morning Corcept Therapeutics Inc is a comm

Tue Dec 30, 2025

$70.19 | -12.06%

Activity

Noteworthy Friday Option Activity: CORT GEV SOFI. Among the underlying components of the Russell 3000 index we saw noteworthy options trading volume today in Corcept Therapeutics Inc (Symbol: CORT) where a total of 4480 contracts have traded so far representing approximately 448000 underlying shares. That amounts to about

Fri Dec 26, 2025

$82.65 | -1.12%

Momentum

UBS Initiates Coverage of Corcept Therapeutics (CORT) with Neutral Recommendation. Fintel reports that on December 16 2025 UBS initiated coverage of Corcept Therapeutics (NasdaqCM:CORT) with a Neutral recommendation. Analyst Price Forecast Suggests 69.88% Upside

Wed Dec 17, 2025

$82.28 | +1.43%

Potential

Rating

Wall Street Firms Tout Corcept Therapeutics Incorporated (CORT) Prospects on Korlym Medication Prospects. Corcept Therapeutics Incorporated (NASDAQ:CORT) is one of the best biotech stocks to buy according to Wall Street analysts. On November 25 H.C. Wainwright reiterated a Buy rating and a $145 price target on the stock citing its strong growth prospects despite commercial challenges. The research firm has reiterated its confidence in the companys Korlym medication [….]

Thu Dec 11, 2025

$87.13 | +2.13%

Potential

Discover CORT Stock analysis and effective trading strategies with StocksRunner.com. Gain valuable insights into stock performance, market trends and the future potential of CORT. We're here to help you make informed investment decisions today.

FIND US ON

Receive our CORT Daily Alerts

Unlock the knowledge that 10,000+ subscribers already cherish. Join for exclusive insights and stay ahead in the stock game! Enter your email to receive daily alerts

Market trends

In-depth stock analysis

Informed investment decisions

Stock market insights

Stock trading tips

Stock analysis

CORT Stock trends

CORT Stock performance

CORT Stock analysis

CORT investment strategies

Stock strategies

Trading strategies

StocksRunner updates

StocksRunner Insights

Financial Reports

Disclaimer: Past performance, whether from actual results or historical strategy tests, does not guarantee future success. The displayed outcomes are based on strategies not previously available to investors and do not depict the returns achieved by any specific investor. The Readiness Indicators, Sentiment Indicators and overall score are derived from a model retrospectively applied using historical data. This model relies on assumptions inherent to it, which may or may not be verifiable and carry potential risks, including losses. Engaging in active trading may not be suitable for individuals with limited resources, minimal investment or trading experience, or a low-risk tolerance. Proceed with caution as your capital is exposed to risks.

Please note that no offer or solicitation to buy or sell securities, securities derivatives of future products of any kind, or any type of trading or invesment advise, recommendation or strategy, is made, given or endorsed by StocksRunner including any of their affiliates ("TS").

This information is provided for illustrative purposes only. You should not rely on any advice and/or information contained in this website and before making any investment decision. we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice.

✕

Don't Be a Sheep, Be a StocksRunner

StocksRunner Aggregates The Most Important Headlines Into A Single Stock IQ

Sign up for free and

continue analysing CORT

Signup to Stocksrunner

Already a Member? Click here to Login

Join us on this journey to revolutionize the way you approach investing. Together, let's navigate the stock market with clarity, confidence and cutting-edge intelligence.

✕

Don't Be a Sheep, Be a StocksRunner

StocksRunner Aggregates The Most Important Headlines Into A Single Stock IQ

Sign up for free and

continue analysing CORT

Signup to Stocksrunner

Already a Member? Click here to Login

Join us on this journey to revolutionize the way you approach investing. Together, let's navigate the stock market with clarity, confidence and cutting-edge intelligence.

CORT Stock Analysis & IQ Rating | Corcept Therapeutics

BQ Stock IQ

CORT Target Price

CORT Risk Level

CORT Analysts Opinion

CORT Street Sentiment

CORT Performance Sentiment

Technical Price Levels

Explore our CORT Stock insights

Receive our CORT Daily Alerts

CORT Street Sentiment

CORT Risk Level

Technical Price Levels

Discover CORT Stock analysis and effective trading strategies with StocksRunner.com. Gain valuable insights into stock performance, market trends and the future potential of CORT. We're here to help you make informed investment decisions today.

Receive our CORT Daily Alerts

CORT Alerts